CIP
LLY icon

Chartwell Investment Partners’s Eli Lilly LLY Stock Holding History

Chartwell Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$28.9M Sell
32,665
-1,305
-4% -$1.17M 0.99% 11
2024
Q2 		$30.8M Buy
33,970
+845
+3% +$676K 1.08% 9
2024
Q1 		$25.8M Sell
33,125
-3,114
-9% -$2.22M 0.89% 14
2023
Q4 		$21.1M Buy
36,239
+3,709
+11% +$2.16M 0.74% 16
2023
Q3 		$17.5M Buy
32,530
+2,649
+9% +$1.37M 0.68% 21
2023
Q2 		$14M Sell
29,881
-3,296
-10% -$1.38M 0.51% 43
2023
Q1 		$11.4M Buy
33,177
+3,173
+11% +$1.07M 0.43% 67
2022
Q4 		$11M Sell
30,004
-3,684
-11% -$1.31M 0.43% 72
2022
Q3 		$10.9M Buy
33,688
+24,196
+255% +$7.67M 0.46% 58
2022
Q2 		$3.08M Sell
9,492
-4,284
-31% -$1.29M 0.12% 234
2022
Q1 		$3.94M Sell
13,776
-358
-3% -$92.1K 0.13% 223
2021
Q4 		$3.9M Buy
14,134
+101
+0.7% +$25.6K 0.11% 238
2021
Q3 		$3.24M Sell
14,033
-6,332
-31% -$1.56M 0.1% 242
2021
Q2 		$4.67M Buy
20,365
+8,150
+67% +$1.64M 0.14% 217
2021
Q1 		$2.28M Sell
12,215
-8,545
-41% -$1.67M 0.07% 264
2020
Q4 		$3.5M Sell
20,760
-185
-0.9% -$27.6K 0.11% 231
2020
Q3 		$3.1M Buy
20,945
+1,300
+7% +$201K 0.11% 224
2020
Q2 		$3.23M Sell
19,645
-20,715
-51% -$3.18M 0.12% 222
2020
Q1 		$5.6M Buy
40,360
+18,354
+83% +$2.52M 0.26% 143
2019
Q4 		$2.89M Sell
22,006
-37
-0.2% -$4.29K 0.1% 243
2019
Q3 		$2.46M Sell
22,043
-64
-0.3% -$7.13K 0.08% 286
2019
Q2 		$2.45M Buy
+22,107
New +$2.6M 0.08% 302
2018
Q3 		– Sell
-8,528
Closed -$728K – 488
2018
Q2 		$728K Buy
+8,528
New +$700K 0.02% 463

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Chartwell Investment Partners's LLY Position: Q3 2024 in Review

Chartwell Investment Partners reduced its Eli Lilly (LLY) stake by 3.8% in Q3 2024, selling an estimated $1.17M and leaving 32,665 shares worth $28.9M. The position accounts for 0.99% of the portfolio, ranked #11.

Chartwell Investment Partners first reported a position in LLY in Q2 2018 and has held it in 23 quarters since. The position peaked at $30.8M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Chartwell Investment Partners held 32,665 shares of Eli Lilly worth $28.9M as of Q3 2024.
  • Chartwell Investment Partners sold 1,305 Eli Lilly shares in Q3 2024, an estimated $1.17M.
  • Eli Lilly made up 0.99% of Chartwell Investment Partners's portfolio in Q3 2024, its #11 holding.
  • Chartwell Investment Partners first reported a position in Eli Lilly in Q2 2018 and has held it in 23 quarters since.
  • Chartwell Investment Partners's Eli Lilly position peaked at $30.8M in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.